Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

Similar articles for PubMed (Select 23250773)

1.

Surface markers in stem cells and cancer from the perspective of glycomic analysis.

Cho HC, Liao CH, Yu AL, Yu J.

Int J Biol Markers. 2012 Dec 27;27(4):e344-52. doi: 10.5301/JBM.2012.10361.

PMID:
23250773
2.

Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.

Mosca E, Cocola C, Sabour D, Pelucchi P, Bertalot G, Palumbo O, Carella M, Götte M, Schöler HR, Reinbold R, Zucchi I, Milanesi L.

In Silico Biol. 2010;10(5-6):207-21. doi: 10.3233/ISB-2010-0437.

PMID:
22430355
3.

Stress resistant human embryonic stem cells as a potential source for the identification of novel cancer stem cell markers.

Mousa SA, Sudha T, Dyskin E, Dier U, Gallati C, Hanko C, Chittur SV, Rebbaa A.

Cancer Lett. 2010 Mar 28;289(2):208-16. doi: 10.1016/j.canlet.2009.08.018. Epub 2009 Sep 4.

PMID:
19733430
4.

Regulation of stem cell plasticity: mechanisms and relevance to tissue biology and cancer.

Strauss R, Hamerlik P, Lieber A, Bartek J.

Mol Ther. 2012 May;20(5):887-97. doi: 10.1038/mt.2012.2. Epub 2012 Feb 7. Review.

5.
6.

Identifying cancer biomarkers by mass spectrometry-based glycomics.

Mechref Y, Hu Y, Garcia A, Hussein A.

Electrophoresis. 2012 Jul;33(12):1755-67. doi: 10.1002/elps.201100715. Review.

7.

Building a framework for embryonic microenvironments and cancer stem cells.

Ruiz-Vela A, Aguilar-Gallardo C, Simón C.

Stem Cell Rev. 2009 Dec;5(4):319-27. doi: 10.1007/s12015-009-9096-7. Review.

PMID:
20058196
8.

Cancer stem cells and markers: new model of tumorigenesis with therapeutic implications.

Natarajan TG, Ganesan N, Fitzgerald KT.

Cancer Biomark. 2010;9(1-6):65-99. doi: 10.3233/CBM-2011-0173. Review.

PMID:
22112470
9.

Threshold in stage-specific embryonic glycotypes uncovered by a full portrait of dynamic N-glycan expression during cell differentiation.

Amano M, Yamaguchi M, Takegawa Y, Yamashita T, Terashima M, Furukawa J, Miura Y, Shinohara Y, Iwasaki N, Minami A, Nishimura S.

Mol Cell Proteomics. 2010 Mar;9(3):523-37. doi: 10.1074/mcp.M900559-MCP200. Epub 2009 Dec 14.

10.

Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms.

Bones J, Byrne JC, O'Donoghue N, McManus C, Scaife C, Boissin H, Nastase A, Rudd PM.

J Proteome Res. 2011 Mar 4;10(3):1246-65. doi: 10.1021/pr101036b. Epub 2011 Jan 19.

PMID:
21142185
11.

Stemming cancer: functional genomics of cancer stem cells in solid tumors.

Regenbrecht CR, Lehrach H, Adjaye J.

Stem Cell Rev. 2008 Dec;4(4):319-28. doi: 10.1007/s12015-008-9034-0. Review.

12.

The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.

Tirino V, Camerlingo R, Franco R, Malanga D, La Rocca A, Viglietto G, Rocco G, Pirozzi G.

Eur J Cardiothorac Surg. 2009 Sep;36(3):446-53. doi: 10.1016/j.ejcts.2009.03.063. Epub 2009 May 22.

PMID:
19464919
13.

Glycomic strategy for efficient linkage analysis of di-, oligo- and polysialic acids.

Galuska SP, Geyer H, Mink W, Kaese P, Kühnhardt S, Schäfer B, Mühlenhoff M, Freiberger F, Gerardy-Schahn R, Geyer R.

J Proteomics. 2012 Sep 18;75(17):5266-78. doi: 10.1016/j.jprot.2012.06.011. Epub 2012 Jun 20.

PMID:
22728599
14.

Cancer stem cell markers as potential targets for epithelial cancers.

Madka V, Rao CV.

Indian J Exp Biol. 2011 Nov;49(11):826-35. Review.

PMID:
22126013
15.

Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells.

Kemper K, Prasetyanti PR, De Lau W, Rodermond H, Clevers H, Medema JP.

Stem Cells. 2012 Nov;30(11):2378-86. doi: 10.1002/stem.1233.

16.

Stem cells in human breast cancer.

Oliveira LR, Jeffrey SS, Ribeiro-Silva A.

Histol Histopathol. 2010 Mar;25(3):371-85. Review.

PMID:
20054808
17.

Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiation.

He H, Nilsson CL, Emmett MR, Marshall AG, Kroes RA, Moskal JR, Ji Y, Colman H, Priebe W, Lang FF, Conrad CA.

J Proteome Res. 2010 May 7;9(5):2098-108. doi: 10.1021/pr900793a.

PMID:
20199106
18.

CXCR4 mediated chemotaxis is regulated by 5T4 oncofetal glycoprotein in mouse embryonic cells.

Southgate TD, McGinn OJ, Castro FV, Rutkowski AJ, Al-Muftah M, Marinov G, Smethurst GJ, Shaw D, Ward CM, Miller CJ, Stern PL.

PLoS One. 2010 Apr 1;5(4):e9982. doi: 10.1371/journal.pone.0009982.

19.

The cancer stem cell marker CD133 interacts with plakoglobin and controls desmoglein-2 protein levels.

Koyama-Nasu R, Takahashi R, Yanagida S, Nasu-Nishimura Y, Oyama M, Kozuka-Hata H, Haruta R, Manabe E, Hoshino-Okubo A, Omi H, Yanaihara N, Okamoto A, Tanaka T, Akiyama T.

PLoS One. 2013;8(1):e53710. doi: 10.1371/journal.pone.0053710. Epub 2013 Jan 10.

20.

Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer.

Jiang Y, He Y, Li H, Li HN, Zhang L, Hu W, Sun YM, Chen FL, Jin XM.

Gastric Cancer. 2012 Oct;15(4):440-50. doi: 10.1007/s10120-012-0140-y. Epub 2012 Feb 14.

PMID:
22395309
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk